P1051: A PHASE 2 STUDY OF IMG-7289 (BOMEDEMSTAT) IN PATIENTS WITH ADVANCED MYELOFIBROSIS

• H. Gill,
• A. Yacoub,
• K. Pettit,
• T. Bradley,
• A. Gerds,
• M. Tatarczuch,
• J. Shortt,
• N. Curtin,
• J. Rossetti,
• K. Burbury,
• A. Mead,
• J. Göthert,
• S. Koschmieder,
• A. Jones,
• J. Peppe,
• J. Dias,
• G. Natsoulis,
• T. McClure,
• M. Kleppe,
• W.-J. Hong,
• W. Stevenson,
• J. Ewing,
• J. Chacko,
• E. Rumi,
• A. Halpern,
• F. Palandri,
• N. Vianelli,
• F. Passamonti,
• R. Mesa,
• M. Marchetti,
• C. Harrison,
• A. Vannucchi,
• J. Watts,
• D. Ross,
• M. Talpaz,
• H. Rienhoff

Affiliations

H. Gill

1 Medicine, University of Hong Kong, Hong Kong, China

A. Yacoub

2 Internal Medicine, The University of Kansas Cancer Center, Leawood

K. Pettit

3 Internal Medicine, University of Michigan, Ann Arbor

T. Bradley

4 Hematology and Medical Oncology, University of Miami, Sylvester Comprehensive Cancer Center, Miami

A. Gerds

5 Hematology and Medical Oncology, Cleveland Clinic, Cleveland, United States of America

M. Tatarczuch

6 Haematology and Oncology, Monash Health

J. Shortt

7 Clinical Sciences, Peter MacCallum

N. Curtin

8 Monash Health, Monash University, Melbourne, Australia

J. Rossetti

9 Medicine, UPMC Hillman Cancer Center, Pittsburgh, United States of America

K. Burbury

10 Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia

A. Mead

11 MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

J. Göthert

12 Hematology, University Hospital Essen, Essen

S. Koschmieder

13 Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Aachen University, Aachen, Germany

A. Jones

14 Hematology

J. Peppe

14 Hematology

J. Dias

15 Basic Sciences

G. Natsoulis

16 Genetics

T. McClure

17 Biometrics, Imago BioSciences, South San Francisco, United States of America

M. Kleppe

15 Basic Sciences

W.-J. Hong

14 Hematology

W. Stevenson

18 Kolling Institute of Medical Research, Royal North Shore Hospital, Sydney, Australia

J. Ewing

19 Haematology, University Hospitals Birmingham, Birmingham

J. Chacko

20 Haematology, The Royal Bournemouth & Christchurch Hospitals, Bournemouth, United Kingdom

E. Rumi

21 Haematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

A. Halpern

22 Medicine, University of Washington, Seattle, United States of America

F. Palandri

23 Azienda Ospedaliero, Universitaria di Bologna Policlinico S.Orsola-Malpighi, Bologna

N. Vianelli

23 Azienda Ospedaliero, Universitaria di Bologna Policlinico S.Orsola-Malpighi, Bologna

F. Passamonti

24 Haematology, University of Insubria, Varese, Italy

R. Mesa

25 UT Health San Antonio Cancer Center, University of Texas Health Science Center, San Antonio, United States of America

M. Marchetti

26 Haematology, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy

C. Harrison

27 Haematology, Guy’s and St Thomas’, London, United Kingdom

A. Vannucchi

28 Center for Research and Innovation of Myeloproliferative Neoplasms, University of Florence, Florence, Italy

J. Watts

29 Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami, United States of America

D. Ross

30 Haematology, Flinders Medical Centre and University, Adelaide, Australia

M. Talpaz

31 Medicine, University of Michigan, Ann Arbor

H. Rienhoff

32 Hematology, Imago BioSciences, San Carlos, United States of America